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Objectives

This is a follow-up study of a sub-cohort from RAHMA study from King Khalid University
Hospital (KKUH). All women from RAHMA database who completed one year since delivery
at KKUH were contacted by phone to participate in the study. Previously collected data from
RAHMA registry for each participant were linked to this study data. Clinical data measured
for each participant included current weight and height to calculate the BMI and waist circumference. Blood tests done for each participant were fasting blood glucose (FPG) and
HbA1c. Based on the blood tests results, participants were classified into three groups; diabetic, pre-diabetic and normal. The incidence of diabetes and prediabetes was calculated
for the whole cohort. Clinical, biochemical, and sociodemographic predictors of glucose
intolerance were compared between the three groups. Risk factors with P-value less than
0.05 were tested in multivariate regression model with bootstrapping to calculate the relative
risk (RR) and its 95% Bias corrected Confidence Interval (C.I.)

Results
From the sub-cohort, 407 women fulfilled the inclusion criteria and agreed to participate in
the study. From the study participants; 250 (61.4%) women were normoglycemic, 142
(35%) women had prediabetes and 15 (3.6%) women were diabetic. Following multivariable
regression analysis only history of gestational diabetes mellitus (GDM), (RR 1.74, 95% CI
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(1.06 to 2.84), P = 0.01), obesity (RR 1.69, 95% CI (1.01–3.11), P = 0.04) and diastolic
blood pressure, (RR 1.04, 95% CI (1.01–1.09), P = 0.03) remained as predictors of postpartum glucose intolerance.
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Conclusion
The incidence of postpartum glucose intolerance (diabetes and prediabetes) is very high in
Saudi women. Both GDM and obesity are strong predictors of glucose intolerance.

Introduction
Diabetes is becoming a global health problem and is one of the main causes of premature morbidity and mortality [1].
Saudi Arabia is one of the top countries with the highest prevalence of diabetes [2]. More
than 25% of Saudi adults are diabetic, with 40% of those are unaware of their condition [3]. In
addition, 25% of the adult population are pre-diabetic [3]
The physiological changes of pregnancy create a state of carbohydrate intolerance mediated
by the pregnancy specific hormones, which increase the peripheral resistance to insulin and
call for more production of the hormone to maintain normal blood glucose levels during pregnancy [4].
One of the commonest glucose metabolism disorders of pregnancy is gestational diabetes
(GDM), which is defined as diabetes diagnosed during pregnancy that is clearly not pre-gestational in nature [5].
It is proven that women with history of GDM are at increased risk of developing type 2 diabetes mellitus, metabolic syndrome and cardiovascular diseases later in life [6,7].
Most of the women with GDM revert to normal glycemic tolerance following delivery,
however, they have seven-fold increased risk of developing type 2 diabetes compared to
women who did not have GDM [8]. The reported rate of progression to type 2 diabetes varied
considerably in different studies and is dependent on the period of follow up, the diagnostic
criteria for GDM and ethnicity of the studied population [9]. Other factors such as family history of type 2 diabetes, severity of hyperglycemia during pregnancy, need of insulin treatment,
and the anthropometric profile of the woman, are predicters of progression to type 2 diabetes
in women with history of GDM [10–13]
Evidence suggests that lifestyle modification and pharmacological interventions can prevent or delay progression to type 2 diabetes in at risk population including women with history
of GDM [14–16]. Hence, the identification of at risk women with history of GDM through
postpartum screening programs, followed by appropriate interventions is expected to reduce
the burden of type 2 diabetes, considering that one in four Saudi women develops GDM during pregnancy and is among the high-risk population for developing type 2 diabetes [17].
As per guidance of American diabetes association (ADA), different tests are equally effective for screening for prediabetes and diabetes including 75 oral glucose tolerance test
(OGTT), fasting plasma glucose (FPG) or glycosylated haemoglobin A1C (HbA1c) [18].
There is paucity of studies on progression to type 2 diabetes among postpartum Saudi
women. The objectives of this study were to determine incidence and risk factors of glucose
intolerance one year after delivery in a sub-cohort of Riyadh Mother and Baby Cohort Study
(RAHMA) study.
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Materials and methods
RAHMA is the first large multicentre, longitudinal cohort study which investigates pregnancy
outcomes in Saudi Arabia. The main objectives of the study were to examine the influence of
non-communicable diseases such as diabetes, hypertension, and obesity, on the mother and
the baby. The participating hospitals were selected randomly after stratification based on the
type of hospital (ministry of health, military, or teaching) and the number of beds which
ensured that the participants in the study were representatives of all the spectra of pregnant
women in Riyadh. The detailed methodology of the study has been previously reported [19].
In brief, participants completed a self-administered questionnaire providing information on
family socioeconomic and lifestyle status and antenatal history. In addition, maternal and neonatal outcomes were reported. A link was established between maternal laboratory data and
the study records [19].
This follow up study was conducted in a sub-cohort of participants of RAHMA from king
Khalid University Hospital (KKUH), which is a tertiary referral hospital with 800 beds. It has
all the essential departments including 20 operating theatres, an assisted reproduction unit
and a cardiac centre. The hospital provides free medical care to Saudi nationals and the staff of
King Saud University. The obstetrics department provides care for 3000–4000 deliveries per
year [19]. The hospital does not provide routine postnatal screening for hyperglycemia for
women with GDM.

Definitions
• GDM was diagnosed based on one or more abnormal value of the 75g oral glucose tolerance
test (OGTT) done between 24 and 34 gestation weeks using the following World Health
Organization (WHO) cut-off values [20]:
Fasting plasma glucose (FPG) 5.1–6.9 mmol/l (92–125 mg/dl).
1-Hour plasma glucose � 10.0 mmol/l (180 mg/dl).
2-Hour plasma glucose 8.5–11.0 mmol/l (153–199 mg/dl).
• Diabetes and prediabetes were diagnosed using either fasting plasma glucose (if the participant came fasting) or glycosylated haemoglobin A1C (HbA1c) levels according to the following cut-off levels of the ADA [18]:
Fasting Plasma Glucose (FPG) values:
Normal < 5.6 mmol/l (100 mg/dl)
Prediabetes 5.6–6.9mmol/l (100 mg/dl to 125 mg/dl)
Diabetes � 7.0 mmol/l (126 mg/dl)
HbA1c values:
Normal < than 5.7% (39 mmol/mol)
Prediabetes 5.7% to 6.4% (39 to 46 mmol/mol)
Diabetes� 6.5% (48 mmol/mol)
• Maternal pre-pregnancy body mass index (BMI) was calculated from maternal recall of
weight prior to pregnancy and height measured during the first antenatal clinic. Current
BMI was calculated using the current maternal weight and height. Participants were
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classified according to the WHO BMI definitions as follows: underweight (<18.5 kg/m2),
normal weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2) and obese (� 30 kg/m2)
[21].
• A tape measure was used by one trained researcher to measure, waist circumference (WC) at
the mid-point, half-way between the right iliac crest and the lower costal region [22].

Study population
This is a follow-up study of subgroup of 3130 women from KKUH. All women who participated in RAHMA study from KKUH and met the inclusion criteria, were contacted one year
after each woman’s delivery date to participate in the study. The inclusion criteria for this subcohort were the following:
1. Gestational age of 37–41 weeks at the time of delivery, calculated from the last menstrual
period and/or early ultrasound scan, when there is a difference between menstrual date and
ultrasound date the latter was taken as the correct date.
2. Singleton pregnancy
We excluded women with unknown glycaemic status, those with pre-GDM diagnosed
before or during pregnancy, women who were pregnant at the time of this study and those
who declined to participate in the study.

Interventions
All women from RAHMA database who delivered one year before at KKUH and fulfilled the
inclusion criteria, were contacted by phone to participate in this study. Women who agreed to
participate were invited to attend RAHMA outpatient clinic (research clinic) fasting for at
least eight hours before their appointment. The objectives of the study were explained again
face-to-face to each participant who subsequently signed an informed consent form. Previously collected data from RAHMA registry for each participant were linked to this study data;
including demographic profile, obstetric history such as parity, pre-pregnancy weight and type
of treatment of GDM in the index pregnancy (diet or insulin). Clinical data measured in each
participant included current weight and height to calculate the BMI in addition to waist circumference WC and systolic and diastolic blood pressure. Blood tests done for each participant were FPG and HbA1c levels.

Outcomes measures
Based on the results of blood tests participants were classified into three groups; diabetic, prediabetic and normal. The incidence of diabetes and prediabetes was calculated in the whole
cohort and the relative risk (RR) of the known risk factors was calculated.

Statistical analysis
Statistical analysis was performed using SPSS version 21.0 (SPSS Inc., Chicago, IL, USA) for
Windows. Descriptive statistics in terms of average ± Standard deviation for quantitative variables and frequency and percentage for qualitative variables were used. Clinical, biochemical,
and sociodemographic characteristics of women who progressed to postpartum glucose intolerance were compared with women with normal glucose tolerance using Bivariate analysis.
One-way Analysis of Variance (ANOVA) was used to compare quantitative variables among
the three groups; normal glucose tolerance, impaired glucose tolerance and diabetics, and
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bootstrapping was conducted to improve precision of estimates. Chi-Square test was used to
evaluate the association between categorical variables and Fisher’s Exact test was used when
indicated.
Different logistic regression models were developed to test the adjusted RR of various risk
factors using modified logistic regression model [23]. All models considered the impairment
of glucose intolerance as a binary outcome and various covariates were adjusted for clinically
significant confounders as maternal age and BMI. Bootstrapping of the regression models was
performed with 1,000 samples and Bias Corrected and accelerated (BCa) 95% Confidence
Intervals (C.I.) were reported. P-value of less than 0.05 was considered as statistically
significant.

Ethical approval
The study was conducted after the approval of King Saud University review board with
approval letter number 15/0445/IRB. The study was conducted according to the principles
expressed in the Declaration of Helsinki.

Results
From a total of 3130 women, who delivered in KKUH and participated in RAHMA study, 712
women did not fulfil the inclusion criteria, 1067 women either declined to participate or had
left the city, 513 women could not be contacted because they changed their contact information and 431 women were not yet one year postpartum when the study concluded leaving 407
women who fulfil the inclusion criteria and agreed to participate in the study (Fig 1).
Table 1 shows comparison of the main determinants of impaired glucose tolerance between
women who participated in the study and those who did not. There was no significant difference between the two groups except for the prevalence of GDM.
Table 2 compares the characteristics of the three groups. From 133 women with history of
GDM; 75 (56.4%) women developed either diabetes or prediabetes, while only 82 (30.1%)
from 272 women without history of GDM developed prediabetes and none from this group

Fig 1. Recruitment and analysis of the cohort.
https://doi.org/10.1371/journal.pone.0210024.g001
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Table 1. Comparison of characteristics of women who participated and those did not participate in the study.
Participants
N = 407

Non-participants
N = 1580

p-value

Age

30.4±5.8

29.9±5.9

0.13

parity

3.17±2.4

3.19±2.2

0.88

Pre-pregnancy BMI

27.6± 5.9

27.9±5.7

0.34

Term BMI

31.7±6.2

31.2±5.6

0.25

FBG

4.6±2.8

4.7±1.8

0.50

GDM

142 (34.9)

285 (18.0)

<0.01

BMI, Body Mass Index; FBG, Fasting blood glucose; GDM, Gestational Diabetes
From the study participants; 250 (61.4%, BCa 95% C.I. = 57.2–66.1%) women were normoglycemic, 142 (35%, BCa 95% C.I. = 30.7–38.8%) women had prediabetes and
15 (3.6%, BCa 95% C.I. = 2.2–5.2%) women were diabetic.
https://doi.org/10.1371/journal.pone.0210024.t001

developed diabetes (Table 2). There was no statistical difference between the three groups in
parity (Table 2). However, normoglycemic women were significantly younger, had significantly lower mean BMI prior to the index pregnancy, compared to women with prediabetes
and diabetes; (27.4 ±5.6, 28.3 ±5.5, 34.3 ±5.5 respectively, P<0.01). Similarly, the current mean
BMI of normoglycemic women was significantly lower than that of the prediabetic and diabetic women (29.3 ± 6.2, 31.1 ± 6.6, 36.2 ± 4.8 respectively, P<0.01). Of the women who developed postpartum diabetes 14 (93.3%) had pre-pregnancy BMI of � 30 kg/m2, while the
corresponding proportion from the prediabetes group and the normoglycemic group was 66
(46.4%) and 108 (43.2%) respectively (Table 2). Measurements of WC and diastolic blood pressure, for women with prediabetes and diabetes, were significantly higher than those of normoglycemic women (Table 2). Significantly more women with prediabetes and diabetes had
family history of diabetes, history of GDM in the index pregnancy, higher mean fating glucose
level and 2 hours post glucose load. In addition, they more frequently needed insulin for control of GDM during pregnancy, compared to normoglycemic women (Table 2).
However, in multivariable logistic regression analysis with bootstrapping, only history of
GDM, (BCa-RR 1.74, 95% C.I. (1.06 to 2.84), P = 0.01), obesity (BCa-RR 1.69, 95% C.I. (1.01–
3.11), P = 0.04) and diastolic blood pressure, (BCa-RR 1.04, 95% C.I. (1.01–1.09), P = 0.03)
remained as predictors of postpartum glucose intolerance (Table 3 and Fig 2).

Discussion
The incidence of prediabetes and diabetes, in this sub-group of RAHMA study, were 35% and
3.6% respectively. The results showed that women who developed glucose intolerance (diabetes and prediabetes), were significantly more obese, during pregnancy and in the postpartum
period. Furthermore, a significantly higher proportion from this group had a history of GDM
and a family history of type 2 diabetes. They had higher diastolic blood pressure and higher
blood glucose levels during pregnancy and they needed insulin more frequently, for control of
GDM, than normoglycemic group. The main predictors of developing glucose intolerance in
this cohort were history of GDM, postpartum obesity and diastolic blood pressure.
This is, to our knowledge, the first study from Saudi Arabia to report on the incidence of
glucose intolerance in postpartum women, one year after delivery. In a national survey of the
general adult population in Saudi Arabia, the prevalence of prediabetes was estimated to be
25%, which is lower than the 35% rate found in this study. Moreover, the incidence (new
cases) of diabetes in this study is higher than the incidence of 1.3% estimated previously for the
same age group and gender by Al-Quwaidhi el al [24]. These differences in incidence and
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Table 2. Comparison of characteristics of women with normal glucose tolerance, impaired glucose tolerance and diabetes.
Normal glucose tolerance (n = 250)

Impaired glucose tolerance(n = 142)

Diabetes (n = 15)

p-value

Pre-pregnancy characteristics
Age (years)

31.6±5.5

32.6±6.2

35.6±5.8

0.02

95% BCa C.I.

30.2–31.8

31.1–33.6

31.2–37.5

0.04
0.49

parity
primiparous

67 (26.9)

35 (24.8)

2 (13.3)

multiparous

183 (73.1)

107 (75.2)

13 (86.7)

Yes

172 (68.7)

112 (78.7)

13 (86.7)

0.04

Pre-pregnancy BMI

27.4 ±5.6

28.3 ±5.5

34.3 ±5.5

<0.01

95% BCa C.I.

26.3–28.1

27.2–29.4

30.8–37.8

<0.01

BMI < 25

84 (33.6)

43 (30.4)

0 (0.0)

<0.01

BMI 25.1–29.9

58 (23.2)

33 (23.2)

1 (6.7)

BMI � 30

108 (43.2)

66 (46.4)

14 (93.3)

Family history of type 2 diabetes

Pregnancy characteristics
Pregnancy glucose level
4.6 ± 0.69

4.8 ±0.64

5.5 ±0.77

<0.01

95% BCa C.I.

4.6–4.8

4.7–4.9

5.1–6.1

<0.01

I hour

7.6 ±1.9

7.9 ±2.2

8.1 ±2.2

0.28

7.22–7.87

7.37–8.61

8.91–10.92

0.16

Fasting

95% BCa C.I.
2 hours

6.3 ± 2.1

6.6 ± 2.1

7.6 ±2.2

0.04

95% BCa C.I.

5.90–6.58

6.08–7.18

8.60–9.01

0.03

58 (23.2)

60 (42.3)

15 (100.0)

<0.01

56 (96.6)

56 (93.3)

9 (60.0)

<0.01

2 (3.4)

4 (6.7)

6 (40.0)

BMI (mean ±SD)

29.3 ± 6.2

31.1 ± 6.6

36.2 ± 4.8

0.01

95% BCa C.I.

28.0–29.9

29.7–32.2

33.9–39.7

<0.01

BMI< 25

69 (27.7)

26 (18.4)

0 (0.0)

<0.01

BMI 25.1–29.9

75 (30.1)

37 (26.2)

2 (13.3)

GDM
Yes
Treatment of GDM
Diet
insulin
Post-pregnancy anthropometric measurements
Current BMI (kg/m2)

BMI � 30

105 (42.2)

78 (55.3)

13 (86.7)

WC (mean ±SD) (cm)

82.4 ± 14.4

87.2 ± 13.0

89.2± 10.0

<0.01

95% BCa C.I.

76.26–79.85

79.76–85.67

87.22–94.07

<0.01

Breast feeding (at 4 months)

110 (44.0)

65 (45.7)

6 (40.0)

0.42

Hormonal contraceptive use

111 (44.4)

53 (37.1)

7(46.7)

0.34

Systolic Blood Pressure

112.9±13.5

113.4±17.5

115.2±14.6

0.80

110.61–114.99

108.53–116.92

112.85–121.90

0.83

67.8±9.2

71.6±8.7

72.5±7.2

0.01

66.35–69.32

69.41–73.45

73.56–75.11

0.03

95% BCa C.I.
Diastolic blood pressure
95% BCa C.I.

95% BCa C.I., 95% Bias Corrected and accelerated Confidence Interval; GDM, Gestational diabetes; BMI, Body Mass Index; WC, Waist circumference
All women who developed type 2 diabetes had history of GDM and none of the women who were normoglycemic during pregnancy developed type 2 diabetes. The RR
of all factors for development of glucose intolerance is shown in Table 3. History of GDM in the index pregnancy almost doubled the risk of developing postpartum
glucose intolerance; (RR 1.91, 95% confidence intervals (C.I.) (1.31 to 2.78), P<0.01). Similarly, women with BMI � 30 kg/m2, had almost double the risk of developing
postpartum glucose intolerance compared to women with lower BMI, (RR 1.79, 95% C.I. (1.17–2.97), P = 0.02) (Table 3). In addition higher diastolic blood pressure
increased the risk of developing diabetes and IGT (RR 1.03, 95% C.I. (1.001–1.066), P = 0.04).
https://doi.org/10.1371/journal.pone.0210024.t002
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Table 3. Relative risk of developing glucose intolerance (prediabetes and type 2 diabetes) among the study cohort.
Risk Factor

RR (95% C.I.)

p- value

BCa RR(95% C.I.)

p-value

Age (years)

1.02(0.98–1.05)

0.41

1.01 (0.98–1.05)

0.43

0.71

0.90 (0.55–1.49)

0.69

0.13

1.27(0.77–2.13)

0.31

parity
primiparous

1

multiparous

1.09 (0.69–1.69)

Family history of DM
no

1

yes

1.41 (0.90–2.20)

Pre-pregnancy BMI
Less than 25

1

25.1–29.9

1.11 (0.63–1.94)

0.72

o.85(0.43–1.54)

0.59

30+

1.28 (0.81–2.03)

0.29

0.95 (0.55–1.69)

0.87

Pregnancy fasting glucose level

1.30 (0.99–1.69)

0.05

1.21 (0.91–1.69)

0.18

<0.01

1.74 (1.06–2.84)

0.01

0.48

1.49(0.53–3.85)

0.42

0.49

GDM
No

1

yes

1.91 (1.31–2.78)

Treatment of GDM
Diet

1

insulin

1.37 (0.56–3.35)

Current BMI (kg/m2)
Less than 25

1

25.1–29.9

1.31 (0.74–2.32)

0.34

1.22 (0.68–2.26)

� 30

1.79 (1.17–2.97)

0.02

1.69 (1.01–3.11)

0.04

Diastolic Blood Pressure

1.03 (1.001–1.066)

0.04

1.04 (1.01–1.09)

0.03

RR, Relative risk; BCa C.I., Bias Corrected and accelerated confidence interval; C.I., Confidence intervals; DM,
Diabetes mellitus; GDM, Gestational Diabetes.
https://doi.org/10.1371/journal.pone.0210024.t003

prevalence may be due to difference in the distribution of the risk factors between the general
population and our cohort which included high proportion of women with GDM.
Recent reports from Italy on the prevalence of hyperglycaemia in women who had GDM
showed rates similar to those found in our study (32% and 4% for prediabetes and diabetes
respectively) [25]. However, reports from Iran showed lower rates than ours for prediabetes
and higher rates for diabetes (17.5% prediabetes and 4.5% type 2 diabetes) [26]. These differences in rates can be explained by the variation in the criteria for diagnosing glucose intolerance, the duration of follow-up period, as both studies examined glycemic tolerance at 6–12
weeks rather than after one year as in our study, in addition to the ethnic differences between
the studied population [8].
Similar to previous reports, this study showed that the risk factors for the development of
impaired glucose tolerance were significantly more prevalent in women who developed diabetes and prediabetes compared to those who remained normoglycemic [8,9]. These include factors existing before the index pregnancy such as pre-pregnancy weight and family history of
type 2 diabetes, factor which occurred during the index pregnancy such as the need to use
insulin to control blood glucose level and high FBG; in addition, to postpartum factors such as
obesity and blood pressure readings.
Nevertheless, when we controlled for confounders, our results showed that only GDM,
postpartum obesity and diastolic blood pressure remained as significant risk factors for the
development of glucose intolerance.
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Fig 2. Forest plot of bias corrected relative risk for developing glucose intolerance.
https://doi.org/10.1371/journal.pone.0210024.g002

Long term follow-up of women with GDM showed a seven to ten-fold increase in risk of
developing type 2 diabetes compared to women who were not diagnosed with GDM [6,27].
The results from a recently published study from Korea showed that history of GDM, as the
sole risk factor, increased the risk of developing diabetes by 2.5-fold [28]. Moreover, women
with the combination of history of GDM and obesity had the highest cumulative incidence of
type 2 diabetes compared to women with combination of any other risk factors [28].
There is great variation in the global prevalence of GDM [29]. Recent reports from Saudi
Arabia estimated that more than 25% of pregnant Saudi women develop GDM based on
World Health Organization diagnostic criteria [17,20]. Such high rate of GDM will continue
to contribute to the epidemic of diabetes and its complications in the country [30] unless a
robust screening program and appropriate interventions are established for this at-risk population [14,15].
Obesity was another predictor of progression to prediabetes and diabetes in this study. Similar results were reported by previously published studies [31,32]. Obesity imposes risk equal
to that of GDM for developing hyperglycemia in postpartum women [28]. In addition, women
with GDM who are obese, have 1.5-fold increase in the risk of developing diabetes in postpartum period compared to those who have normal BMI [32]. Recent reports from Saudi Arabia
showed that more than 68% of women in the reproductive age group are either overweight or
obese [19], and that the prevalence of GDM and Pre-GDM increases with the increase in BMI
[17].
Another risk factor for persistent hyperglycemia in the postpartum period is diastolic blood
pressure. Although blood pressure levels for all groups in this study were blew those of hypertension [33], but higher diabolic blood pressure was a predictor of development of hyperglycemia. Similar results were reported by Vambergue et al who speculated that most of the women
who develop hyperglycemia following GDM will develop hypertension later in life [34]
Based on a recently published systematic review, lifestyle interventions, including healthy
eating and physical activity, are effective for the treatment of women with GDM [35]. Women
who received lifestyle interventions were more likely to achieve the target weight in the postnatal period and their neonates were less likely to be large for gestational age [35]. Furthermore,
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lifestyle interventions following delivery were effective in the prevention of progression to type
2 diabetes [36].

Strength and limitations of the study
This study is the first to quantify the problem of glucose intolerance following GDM in a Saudi
population. It provides valuable information for policy makers and researchers about the risk
factors for progression to type 2 diabetes in Saudi women. However, the study population may
not be representative of the whole population especially that there were significantly more
women with GDM in the study group compared to the women who did not participate in the
study (Table 1). This may be due to the fact that women who had pregnancies complicated
with GDM were concerned about their health and were more willing to participate in the
study than those who had normal pregnancy. Another limitation of this study is the relatively
small number of participants compared to the total number of women who participated in
RAHM from KKUH. This is due to the poor return of participants from the first cohort. Poor
postpartum response to recall for follow-up is faced by other researchers in the Middle East
[37]. Many factors contribute to this phenomenon including inadequate referral system, lack
of national health information system, and lack of national registries in addition to the lack of
the culture of longitudinal research in many of the Middle Eastern communities.

Implication to practice
• Establishing a national program for screening adults, especially for women with history of
GDM, for diabetes and prediabetes is a prudent step towards controlling the epidemic of diabetes in the country. Such programs were proven to be cost-effective given the saving in
averting the cost of morbidity and premature death from complications of diabetes [38].
• Implementation of evidence based strategy for the treatment of GDM that includes lifestyle
modification is an essential step in the control of postpartum progression to type 2 diabetes
• It is important to increase the awareness of Saudi women in the reproductive age group
about the risks related to obesity and GDM and the importance of postnatal screening

Implication to research
Research should be directed towards effective interventions to reduce the burden of obesity in
Saudi pregnant and postpartum women.

Conclusion
The incidence of postpartum glucose intolerance (diabetes and prediabetes) is very high in
Saudi women. Both GDM and obesity are strong predictors of glucose intolerance.

Acknowledgments
Our thanks are due to all women who participated in the study and to Mrs Ruba Elawad and
all the laboratory technicians for their efforts and detection. We would like to extend our gratitude to the Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University
for funding this study. HW and AF are responsible about the design, access to data, and the
decision to submit and publish the manuscript.

PLOS ONE | https://doi.org/10.1371/journal.pone.0210024 January 7, 2019

10 / 13

RAHMA; incidence of postpartum glucose intolerance

Author Contributions
Conceptualization: Hayfaa Wahabi, Amna R. Siddiqui.
Data curation: Safaa M. S. Tunkar, Ali M. Al-Hazmi, Samia Esmaeil.
Formal analysis: Amel Fayed.
Funding acquisition: Amel Fayed, Hanadi Bakhsh.
Investigation: Amel Fayed.
Methodology: Hayfaa Wahabi, Amel Fayed.
Project administration: Samia Esmaeil.
Supervision: Hayfaa Wahabi, Samia Esmaeil, Amna R. Siddiqui.
Validation: Hanadi Bakhsh.
Writing – original draft: Hayfaa Wahabi.
Writing – review & editing: Hayfaa Wahabi, Amel Fayed, Hanadi Bakhsh, Amna R. Siddiqui.

References
1.

Booth GL, Kapral MK, Fung K, Tu JV (2006) Relation between age and cardiovascular disease in men
and women with diabetes compared with non-diabetic people: a population-based retrospective cohort
study. Lancet 368: 29–36. S0140-6736(06)68967-8 [pii]; https://doi.org/10.1016/S0140-6736(06)
68967-8 PMID: 16815377

2.

Majeed A, El-Sayed AA, Khoja T, Alshamsan R, Millett C, Rawaf S, et al. (2014) Diabetes in the MiddleEast and North Africa: an update. Diabetes Res Clin Pract 103: 218–222. S0168-8227(13)00391-4
[pii]; https://doi.org/10.1016/j.diabres.2013.11.008 PMID: 24300017

3.

Al-Rubeaan K, Al-Manaa HA, Khoja TA, Ahmad NA, Al-Sharqawi AH, Siddiqui K, et al. (2015) Epidemiology of abnormal glucose metabolism in a country facing its epidemic: SAUDI-DM study. J Diabetes 7:
622–632. https://doi.org/10.1111/1753-0407.12224 PMID: 25266306

4.

Ryan EA, Enns L (1988) Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 67: 341–347. https://doi.org/10.1210/jcem-67-2-341 PMID: 3292560

5.

American Diabetes association (2016) Management of diabetes in pregnancy. Diabetes Care 39: S94–
S98. https://doi.org/10.2337/dc16-S015 PMID: 26696688

6.

Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373: 1773–1779. S0140-6736(09)60731-5 [pii];
https://doi.org/10.1016/S0140-6736(09)60731-5 PMID: 19465232

7.

Gunderson EP, Chiang V, Pletcher MJ, Jacobs DR, Quesenberry CP, Sidney S, et al. (2014) History of
gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the Coronary Artery Risk
Development in Young Adults study. J Am Heart Assoc 3: e000490. jah3472 [pii]; https://doi.org/10.
1161/JAHA.113.000490 PMID: 24622610

8.

Tovar A, Chasan-Taber L, Eggleston E, Oken E (2011) Postpartum screening for diabetes among
women with a history of gestational diabetes mellitus. Prev Chronic Dis 8: A124. A124 [pii]. PMID:
22005617

9.

Leuridan L, Wens J, Devlieger R, Verhaeghe J, Mathieu C, Benhalima K (2015) Glucose intolerance in
early postpartum in women with gestational diabetes: Who is at increased risk? Prim Care Diabetes 9:
244–252. S1751-9918(15)00042-X [pii]; https://doi.org/10.1016/j.pcd.2015.03.007 PMID: 25899304

10.

Baptiste-Roberts K, Barone BB, Gary TL, Golden SH, Wilson LM, Bass EB, et al. (2009) Risk factors for
type 2 diabetes among women with gestational diabetes: a systematic review. Am J Med 122: 207–
214. S0002-9343(08)00981-9 [pii]; https://doi.org/10.1016/j.amjmed.2008.09.034 PMID: 19272478

11.

Eades CE, Styles M, Leese GP, Cheyne H, Evans JM (2015) Progression from gestational diabetes to
type 2 diabetes in one region of Scotland: an observational follow-up study. BMC Pregnancy Childbirth
15: 11. https://doi.org/10.1186/s12884-015-0457-8 s12884-015-0457-8 [pii]. PMID: 25643857

12.

Feig DS, Zinman B, Wang X, Hux JE (2008) Risk of development of diabetes mellitus after diagnosis of
gestational diabetes. CMAJ 179: 229–234. 179/3/229 [pii]; https://doi.org/10.1503/cmaj.080012 PMID:
18663202

PLOS ONE | https://doi.org/10.1371/journal.pone.0210024 January 7, 2019

11 / 13

RAHMA; incidence of postpartum glucose intolerance

13.

Rayanagoudar G, Hashi AA, Zamora J, Khan KS, Hitman GA, Thangaratinam S (2016) Quantification
of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta-analysis of
95,750 women. Diabetologia 59: 1403–1411. https://doi.org/10.1007/s00125-016-3927-2 [pii]. PMID:
27073002

14.

Hod M, Hadar E, Cabero-Roura L (2015) Prevention of type 2 diabetes among women with prior gestational diabetes mellitus. Int J Gynaecol Obstet 131 Suppl 1: S16–S18. S0020-7292(15)00089-2 [pii];
https://doi.org/10.1016/j.ijgo.2015.02.010 PMID: 26433497

15.

O’Reilly SL, Dunbar JA, Versace V, Janus E, Best JD, Carter R, et al. (2016) Mothers after Gestational
Diabetes in Australia (MAGDA): A Randomised Controlled Trial of a Postnatal Diabetes Prevention Program. PLoS Med 13: e1002092. https://doi.org/10.1371/journal.pmed.1002092 PMEDICINE-D-1601046 [pii]. PMID: 27459502

16.

Peacock AS, Bogossian F, McIntyre HD, Wilkinson S (2014) A review of interventions to prevent Type 2
Diabetes after Gestational Diabetes. Women Birth 27: e7–e15. S1871-5192(14)00088-2 [pii]; https://
doi.org/10.1016/j.wombi.2014.09.002 PMID: 25262356

17.

Wahabi H, Fayed A, Esmaeil S, Mamdouh H, Kotb R (2017) Prevalence and Complications of Pregestational and Gestational Diabetes in Saudi Women: Analysis from Riyadh Mother and Baby Cohort Study
(RAHMA). Biomed Res Int 2017: 6878263. https://doi.org/10.1155/2017/6878263 PMID: 28386562

18.

American Diabetes association (2018) Standards of Medical Care in Diabetes-2018. Diabetes Care 41:
S55—S64. https://doi.org/10.2337/dc18-S006 PMID: 29222377

19.

Wahabi H, Fayed A, Esmaeil S, Alzeidan R, Elawad M, Tabassum R, et al. (2016) Riyadh Mother and
Baby Multicenter Cohort Study: The Cohort Profile. PLoS One 11: e0150297. https://doi.org/10.1371/
journal.pone.0150297 PONE-D-15-43377 [pii]. PMID: 26937965

20.

World Health Organization (2014) Diagnostic criteria and classification of hyperglycaemia first detected
in pregnancy. Diabetes Res Clin Pract 103: 341–363. PMID: 24847517

21.

World Health Organization (2015) Global database on body mass index: BMI classification.

22.

Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, et al. (2003) Waist circumference,
waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 254: 555–563. 1229 [pii]. PMID: 14641796

23.

Diaz-Quijano FA (2012) A simple method for estimating relative risk using logistic regression. BMC Med
Res Methodol 12: 14. 1471-2288-12-14 [pii]; https://doi.org/10.1186/1471-2288-12-14 PMID:
22335836

24.

Al-Quwaidhi AJ, Pearce MS, Sobngwi E, Critchley JA, O’Flaherty M (2014) Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies. Diabetes Res Clin Pract 103: 496–503. S0168-8227(13)
00470-1 [pii]; https://doi.org/10.1016/j.diabres.2013.12.036 PMID: 24447810

25.

Capula C, Chiefari E, Vero A, Foti DP, Brunetti A, Vero R (2014) Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus. Diabetes Res Clin Pract
105: 223–230. S0168-8227(14)00231-9 [pii]; https://doi.org/10.1016/j.diabres.2014.05.008 PMID:
24931701

26.

Nouhjah S, Shahbazian H, Shahbazian N, Jahanshahi A, Jahanfar S, Cheraghian B (2017) Incidence
and Contributing Factors of Persistent Hyperglycemia at 6–12 Weeks Postpartum in Iranian Women
with Gestational Diabetes: Results from LAGA Cohort Study. J Diabetes Res 2017: 9786436. https://
doi.org/10.1155/2017/9786436 PMID: 28491872

27.

Herath H, Herath R, Wickremasinghe R (2017) Gestational diabetes mellitus and risk of type 2 diabetes
10 years after the index pregnancy in Sri Lankan women-A community based retrospective cohort
study. PLoS One 12: e0179647. https://doi.org/10.1371/journal.pone.0179647 PONE-D-17-00509
[pii]. PMID: 28644881

28.

Cho GJ, Park JH, Lee H, Yoo S, Shin SA, Oh MJ (2016) Prepregnancy Factors as Determinants of the
Development of Diabetes Mellitus After First Pregnancy. J Clin Endocrinol Metab 101: 2923–2930.
https://doi.org/10.1210/jc.2015-3761 PMID: 27159192

29.

Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG (2012) Gestational diabetes mellitus: results
from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 25: 600–610. https://
doi.org/10.3109/14767058.2011.587921 PMID: 21762003

30.

Robert AA, Al Dawish MA, Braham R, Musallam MA, Al Hayek AA, Al Kahtany NH (2017) Type 2 Diabetes Mellitus in Saudi Arabia: Major Challenges and Possible Solutions. Curr Diabetes Rev 13: 59–64.
https://doi.org/10.2174/1573399812666160126142605 CDR-EPUB-73240 [pii]. PMID: 26813972

31.

Cheung NW, Helmink D (2006) Gestational diabetes: the significance of persistent fasting hyperglycemia for the subsequent development of diabetes mellitus. J Diabetes Complications 20: 21–25. S10568727(05)00043-7 [pii]; https://doi.org/10.1016/j.jdiacomp.2005.05.001 PMID: 16389163

PLOS ONE | https://doi.org/10.1371/journal.pone.0210024 January 7, 2019

12 / 13

RAHMA; incidence of postpartum glucose intolerance

32.

Lobner K, Knopff A, Baumgarten A, Mollenhauer U, Marienfeld S, Garrido-Franco M, et al. (2006) Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 55: 792–797. 55/
3/792 [pii]. PMID: 16505245

33.

Armstrong C (2018) High Blood Pressure: ACC/AHA Releases Updated Guideline. Am Fam Physician
97: 413–415. d13680 [pii]. PMID: 29671535

34.

Vambergue A, Dognin C, Boulogne A, Rejou MC, Biausque S, Fontaine P (2008) Increasing incidence
of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy:
DIAGEST 2 study. Diabet Med 25: 58–64. DME2306 [pii]; https://doi.org/10.1111/j.1464-5491.2007.
02306.x PMID: 18028442

35.

Brown J, Alwan NA, West J, Brown S, McKinlay CJ, Farrar D, et al. (2017) Lifestyle interventions for the
treatment of women with gestational diabetes. Cochrane Database Syst Rev 5: CD011970. https://doi.
org/10.1002/14651858.CD011970.pub2 PMID: 28472859

36.

Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E, et al. (2015) The
effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and
without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J
Clin Endocrinol Metab 100: 1646–1653. https://doi.org/10.1210/jc.2014-3761 PMID: 25706240

37.

Shahbazian H, Nouhjah S, Jahanfar S, Nasiri M (2015) Recall for postpartum follow-up of women with
gestational diabetes mellitus: Climbing a mountain. J Diabetes Metab Disord 15: 20. https://doi.org/10.
1186/s40200-016-0245-7 245 [pii]. PMID: 27376036

38.

Marseille E, Lohse N, Jiwani A, Hod M, Seshiah V, Yajnik CS, et al. (2013) The cost-effectiveness of
gestational diabetes screening including prevention of type 2 diabetes: application of a new model in
India and Israel. J Matern Fetal Neonatal Med 26: 802–810. https://doi.org/10.3109/14767058.2013.
765845 PMID: 23311860

PLOS ONE | https://doi.org/10.1371/journal.pone.0210024 January 7, 2019

13 / 13

